Mylan

Official page for Mylan, where we work around the clock and around the globe to help provide 7 billion people access to high quality medicine

Suggest edits

Follow us

Alexa global traffic share

Twitter followers

Built with ❤︎ by Datalicious ©2021
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Apps 7

Add info

Team Size

10000+

Employees

I work here

Location

United States

Headquarters

Explore United States

Biogen fends off Mylan’s challenge to patent on top-selling multiple sclerosis drug

Mylan to pay $30 million U.S. SEC fine related to EpiPen overcharge probe

Denmark's Novo Nordisk files lawsuit against Mylan over patent

Mylan to merge with Upjohn

Pfizer in talks to merge off-patent drugs business with Mylan: source

Mylan Critic Blumenthal Asks FDA to Help End EpiPen Shortage

Health Manufacturing

72% of Mylan shareholders think Heather Bresch is doing great—just overpaid

Strategy

Mylan board survives shareholder vote, but gets pushback on its compensation

Strategy

With help of coal tax credits, Mylan had a negative 294-percent tax rate in 2016

Stock markets Strategy

Mylan chairman: Drug pricing critics ought to go copulate with themselves

Costs Communities Health

How Mylan got away with overcharging Medicaid $1.3 billion for EpiPen

Health Privacy

Mylan shareholders revolt, say directors’ greed has gone too far

Stock markets

Mylan bullied, sued states to get them to use EpiPens, court documents show

Legal Health

FDA lashes out at Mylan for dismal quality control at HIV drug facility

Health

Despite what Mylan said, its price hikes hit patients’ wallets hard

Health Costs Earnings

EpiPen maker Mylan is under investigation by the Federal Trade Commission

US elections

For ripping off Medicaid, EpiPen maker Mylan pays Feds $465 million

Health Costs Privacy

Feds Go After Mylan For Scamming Medicaid Out of Millions On EpiPen Pricing

Mylan CEO misled lawmakers about EpiPen profits—they’re 66% higher

Earnings

Index

By TNW

Mylan

Mylan

Overview

Apps 7

Biogen fends off Mylan’s challenge to patent on top-selling multiple sclerosis drug

Mylan to pay $30 million U.S. SEC fine related to EpiPen overcharge probe

Denmark's Novo Nordisk files lawsuit against Mylan over patent

Pfizer to merge generics unit with Mylan; seeks to sharpen cancer...

Mylan to merge with Upjohn

Pfizer in talks to merge off-patent drugs business with Mylan: source

Mylan Critic Blumenthal Asks FDA to Help End EpiPen Shortage

72% of Mylan shareholders think Heather Bresch is doing great—just overpaid

Mylan board survives shareholder vote, but gets pushback on its compensation

With help of coal tax credits, Mylan had a negative 294-percent tax rate in 2016

Mylan chairman: Drug pricing critics ought to go copulate with themselves

How Mylan got away with overcharging Medicaid $1.3 billion for EpiPen

Mylan shareholders revolt, say directors’ greed has gone too far

Mylan bullied, sued states to get them to use EpiPens, court documents show

FDA lashes out at Mylan for dismal quality control at HIV drug facility

Despite what Mylan said, its price hikes hit patients’ wallets hard

EpiPen maker Mylan is under investigation by the Federal Trade Commission

For ripping off Medicaid, EpiPen maker Mylan pays Feds $465 million

Feds Go After Mylan For Scamming Medicaid Out of Millions On EpiPen Pricing

Mylan CEO misled lawmakers about EpiPen profits—they’re 66% higher